comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 16:24:30 - browse：1

intarcia implant. -- health tech coverage from STAT — The matchstick-sized, implantable device from Intarcia Therapeutics releases a steady, continuous, and low-dose stream of a drug for diabetes. Stuart Isett/Fortune Brainstorm Health

An advisory panel to the Food and Drug Administration unanimously voted against a diabetes implant from Intarcia Therapeutics — a former biotech unicorn that faltered after the FDA rejected said implant not once, but twice.

Intarcia called for the panel meeting because of those two rejections, seeking outside input on the FDA’s decision. FDA then granted Intarcia’s request. The agency is not bound to advisory panel decisions, though it tends to follow their advice.

Intarcia started developing its lead therapy, a small, skinny bar implanted under the skin, for type 2 diabetes patients in 2016. The implant delivers a glucose-controlling medicine called exenatide, a member of the GLP-1 drugs that have taken the diabetes and obesity markets by storm. Intarcia’s implant continuously administers the drug over six months, with the goal of improving patient adherence compared to Eli Lilly and Novo Nordisk’s weekly GLP-1 shots.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Guardant Health colon cancer test endorsed by FDA advisory panel

hotspot

WSS

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

The world needs the new pandemic treaty

The world needs the new pandemic treaty

U.S. death rates show how politics are affecting public health

Bird flu makes raw milk dangerous to consume, mouse study finds

Families look for replacement for GSK asthma drug Flovent

explore

comprehensive

knowledge

After affirmative action ruling, medical educators look to 'holistic review'

Harvard's David Sinclair gets blowback over aging

Sports medicine is finally prioritizing gender equality

Lawsuit challenges CMS nursing home minimum staffing rule

In Memoriam: Notable people who died in 2023

Decentralized clinical trials need collaboration to achieve wider use

Trump demands the U.S. pay no more for drugs than other countries … again

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Medical leaders decry Supreme Court decision on affirmative action

Lack of health data on LGBTQ+ people has serious consequences

explore

He's 19 months old and has one of the world’s rarest diseases

State of the Union pitch: Bigger Medicare drug price negotiations

First over

The untold story of TV’s first prescription drug ad

Harvard's David Sinclair gets blowback over aging

Clinicians often fail to acknowledge the pain caused by long Covid

knowledge

leisure time

hotspot

leisure time